place of glibenclamide in the dialectics of modern glucose-lowering therapy in terms of safety and cardioprotection
Clicks: 207
ID: 167495
2013
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
207 views
15 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #44 of 79 articles by views in Macromolecular rapid communications
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
.
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (0 words).
Try re-searching for a better abstract.
| Reference Key |
pankiv2013mnarodnijplace
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;V.I. Pankiv |
| Journal | Macromolecular rapid communications |
| Year | 2013 |
| DOI |
10.22141/2224-0721.2.50.2013.84280
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.